Skip to main content

Animations

MJFF Publications

1861 - 1870 of 8785 Results
Title
Year
  • Year
  • 2024
  • 2020
  • 2020
  • 2021
  • 2017
  • 2019
  • 2019
  • 2019
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Benchmarking of a multi‐biomarker low‐volume panel for Alzheimer's disease and related dementia research
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14413
    Citation Count: 13
  • Summary Details
    OPEN
    Title: TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson’s Disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2020.108418
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson’s disease
    Journal Name: Cytokine: X
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cytox.2020.100027
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Neurosurgeons perspective on the shift towards earlier use of deep brain stimulation for Parkinson disease
    Journal Name: Interdisciplinary Neurosurgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.inat.2021.101224
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Increased odds of bladder and bowel symptoms in early Parkinson's disease
    Journal Name: Neurourology and Urodynamics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/nau.23443
    Citation Count: 10
  • Summary Details
    OPEN
    Title: SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27642
    Citation Count: 104
  • Summary Details
    OPEN
    Title: Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-019-1636-8
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27807
    Citation Count: 27
  • Summary Details
    OPEN
    Title: The angiotensin (1–7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114926
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Altered Neural Activation in First Episode Psychosis Patients With Comorbid Conduct Disorder: A Pilot Investigation
    Journal Name: JAACAP Open
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jaacop.2024.04.001
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.